| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Shikonin | 517-89-5 | sc-200391 sc-200391A | 10 mg 50 mg | $75.00 $223.00 | 13 | |
Shikonin, a natural compound from certain plants, has been studied as a potential inhibitor of PKM2. It may target PKM2 by interfering with its activity or regulation, affecting glycolysis in cancer cells. Shikonin's specific mechanism of action on PKM2 may involve modulation of its enzymatic activity or its role in metabolic pathways. | ||||||
Oxalomalic acid sodium salt | 89304-26-7 | sc-295985 sc-295985A | 1 mg 5 mg | $51.00 $153.00 | ||
Oxalomalate inhibits PKM2 activity, likely by interacting with the enzyme and modulating its enzymatic function. This interference alters glycolytic pathways in cancer cells, potentially impacting their metabolic processes and growth. | ||||||
Phosphoenolpyruvic acid, monopotassium salt | 4265-07-0 | sc-208168 sc-208168A sc-208168B | 100 mg 250 mg 1 g | $76.00 $152.00 $296.00 | 1 | |
PEP, an endogenous metabolite, can inhibit PKM2 by binding to the enzyme and regulating its activity. This regulation affects the glycolytic rate in cancer cells, providing insights into potential strategies for metabolic manipulation in cancer therapy. | ||||||
Tyrphostin A23 | 118409-57-7 | sc-3554 | 10 mg | $110.00 | 13 | |
Tyrphostin AG-1 has been studied for its effects on PKM2. Its mechanism of action involves inhibiting PKM2 activity and potentially influencing glycolytic pathways in cancer cells, presenting a potential avenue for targeting cancer metabolism. | ||||||